Skip to content

Investigator

Erol Fikrig

YALE UNIVERSITY · funded by NIAID

Companies
3

Resolved onto their grants.

Grants
7

Federal awards on file.

Non-dilutive funding
$4.2M

Summed across those awards.

First award
Jul 13, 2018

Latest Jul 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Systematic identification of interactions between Lyme Borrelia and Ixodes scapularis

    $461k

    Jul 1, 2025NIAIDYALE UNIVERSITYNIH RePORTER · 11195833 (opens the source filing in a new tab)

  2. R41

    The mosquito salivary protein AgBR1 as vaccine candidate against Chikungunya

    $300k

    Jul 17, 2024NIAIDL2 DIAGNOSTICS, LLCNIH RePORTER · 11140413 (opens the source filing in a new tab)

  3. R41

    A novel therapeutic for Lyme arthritis based on a secretory leukocyte protease inhibitor

    $300k

    Jul 8, 2024NIAIDL2 DIAGNOSTICS, LLCNIH RePORTER · 11134674 (opens the source filing in a new tab)

  4. R01

    A novel Lyme disease vaccine

    $1.3M

    Jun 7, 2022NIAIDYALE UNIVERSITYNIH RePORTER · 11086012 (opens the source filing in a new tab)

  5. R01

    Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice

    $785k

    Apr 14, 2021NIAIDYALE UNIVERSITYNIH RePORTER · 11056125 (opens the source filing in a new tab)

  6. P01

    Tick Immune-Developmental and Metabolic Pathways as Anti-Tick Vaccine Targets

    $517k

    Jul 13, 2018NIAIDUNIV OF MARYLAND, COLLEGE PARKNIH RePORTER · 11112746 (opens the source filing in a new tab)

  7. P01

    Tick Immune-Developmental and Metabolic Pathways as Anti-Tick Vaccine Targets

    $583k

    Jul 13, 2018NIAIDUNIV OF MARYLAND, COLLEGE PARKNIH RePORTER · 11268000 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources